McCaw ZR, Tian L, Wei LJ. Evaluating the Duration of Response With Mirvetuximab Soravtansine for Treating Platinum-Resistant Ovarian Cancer. J Clin Oncol 2023 Aug 3:JCO2300288. doi: 10.1200/JCO.23.00288.
PMID: 37535885